| 000 | 00772 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250511154248.0 | ||
| 264 | 0 | _c19770812 | |
| 008 | 197708s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 024 | 7 |
_a10.1016/s0022-5347(17)58643-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKleeman, F J | |
| 245 | 0 | 0 |
_aPhenoxybenzamine. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cJun 1977 |
||
| 300 |
_a814 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhenoxybenzamine _xadverse effects |
| 650 | 0 | 4 |
_aUrinary Bladder, Neurogenic _xdrug therapy |
| 773 | 0 |
_tThe Journal of urology _gvol. 117 _gno. 6 _gp. 814 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-5347(17)58643-7 _zAvailable from publisher's website |
| 999 |
_c882736 _d882736 |
||